TCH GROUP, LLC for SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC )
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
All provisions of S369 "Protecting Access to Affordable Generic Drugs Act of 2009"; and HR 1706 "Protecting Consumer Access to Generic Drugs Act of 2009"; all provisions of S515 "The Patent Reform Act of 2009" and HR 1260 "The Patent Refrom Act of 2009"; HR 4872, "Health Care & Education Reconciliation Act of 2010" provisions related to patent settlements.
Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Medicare/Medicaid MMM
Issues related to vaccine administration payment under the Medicaid program.
Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Taxation/Internal Revenue Code TAX
Extension of the R&D tax credit and all such provisions in HR4213, "American Workers, State, and Business Relief Act of 2010"; HR422 "To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit"; and S1203 "Grow Research Opportunities with Tax Credits' Help Act" or "GROWTH Act".
Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Health Issues HCR
HR3692 "To provide affordable, quality health care for all Americans and reduce growth in health care spending, and for other purposes"; HR 4872 "Health Care and Education Reconciliation Act of 2010"; HR3590 "The Patient Protection and Affordable Care Act"- provisions related to follow-on biologics, comparative effectiveness research, 340B programs and the Independent Payment Advisory Board; issues related to prescription drug safety and heparin; issues related to cancer awareness and access to treatment.
Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.